Intracept

Device Relievant Medsystems, Inc.
Total Payments
$8.1M
Transactions
34,008
Doctors
7,131
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $597,987 4,837 1,806
2023 $2.3M 14,298 3,714
2022 $2.0M 7,692 2,557
2021 $917,082 4,714 1,793
2020 $314,023 1,143 463
2019 $2.1M 1,324 484

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.3M 283 27.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2.2M 1,449 27.0%
Travel and Lodging $1.5M 5,358 18.4%
Food and Beverage $1.5M 26,553 18.0%
Consulting Fee $700,815 365 8.6%

Payments by Type

General
$5.9M
33,725 transactions
Research
$2.3M
283 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
INTRACEPT Relievant Medsystems, Inc. $1.0M 0
CLBP Single Arm Case Series Relievant Medsystems, Inc. $494,065 0
ISR 0010 Meta Analysis Intracept vs Non Surgical Pain Intervention Relievant Medsystems, Inc. $176,489 0
Intracept Relievant Medsystems, Inc. $138,062 0
Single Arm Cohort Study Relievant Medsystems, Inc. $94,893 0
SMART 5 Plus Year Follow-up Study Relievant Medsystems, Inc. $90,552 0
HECON Utilization Analysis Relievant Medsystems, Inc. $25,908 0
ISR 0007 Intracept Registry Pilot Phase II Relievant Medsystems, Inc. $25,713 0
Pain Characteristics Relievant Medsystems, Inc. $25,395 0
Imaging Characteristics Study Relievant Medsystems, Inc. $21,300 0
Meta-Analysis Relievant Medsystems, Inc. $20,475 0
ISR 0003 Intracept Registry Pilot Relievant Medsystems, Inc. $18,888 0
CLBP Single Arm 5 Year Follow Up Relievant Medsystems, Inc. $16,455 0
VERTEBROGENIC PAIN PATIENT CHARACTERISTS Relievant Medsystems, Inc. $15,775 0
ISR 0006 Pain Body Diagram Mapping Relievant Medsystems, Inc. $14,529 0
ISR 0009 Vertebrogenic Pain Imaging Characteristics Relievant Medsystems, Inc. $14,529 0
Patient Characteristics manuscript Relievant Medsystems, Inc. $13,110 0
Targeted Ablation Zone MRI Study Relievant Medsystems, Inc. $12,985 0
ISR 0002 Patient Characteristics Regression Relievant Medsystems, Inc. $11,116 0
Intracept Case Series_TBI Relievant Medsystems, Inc. $10,707 0

Top Doctors Receiving Payments for Intracept — Page 2

Doctor Specialty Location Total Records
, NP Family Venice, FL $41,083 118
, PA-C Physician Assistant Brockton, MA $39,541 173
, MD Vascular & Interventional Radiology Edmond, OK $38,438 65
, PA-C Physician Assistant Eugene, OR $30,761 102
, MD, DABA, DAPM Anesthesiology Staten Island, NY $27,687 67
, M.D Physical Medicine & Rehabilitation Little Rock, AR $26,831 87
, NP Family Medicine Draper, UT $25,647 119
, D.O Orthopaedic Surgery Plano, TX $23,374 38
, MD Anesthesiology Garden City, NY $17,795 57
, MD Neurological Surgery San Antonio, TX $17,411 39
David Tran Physical Medicine & Rehabilitation Berwyn, IL $17,321 60
, MD Anesthesiology West Islip, NY $15,468 59
, MD Diagnostic Radiology Royal Oak, MI $14,836 8
, MD Interventional Pain Medicine Marietta, GA $14,801 19
, M.D Interventional Pain Medicine San Francisco, CA $14,413 3
, MD Physical Medicine & Rehabilitation Southlake, TX $13,492 36
, M.D Orthopaedic Surgery of the Spine Southlake, TX $13,141 20
, MD Vascular & Interventional Radiology Birmingham, AL $12,208 31
, M.D Neurological Surgery Fountain Hill, PA $11,554 29
, PA-C Physician Assistant Little Rock, AR $10,139 44
, M.D Pain Medicine Washington, DC $9,905 28
, M.D Anesthesiology Cape Girardeau, MO $9,867 32
, M.D Orthopaedic Surgery Houston, TX $9,075 1
, MD Anesthesiology Rockville Centre, NY $8,025 28
, NP-C Adult Health Lynbrook, NY $5,826 84

About Intracept

Intracept is a device associated with $8.1M in payments to 7,131 healthcare providers, recorded across 34,008 transactions in the CMS Open Payments database. The primary manufacturer is Relievant Medsystems, Inc..

Payment data is available from 2019 to 2024. In 2024, $597,987 was paid across 4,837 transactions to 1,806 doctors.

The most common payment nature for Intracept is "Unspecified" ($2.3M, 27.9% of total).

Intracept is associated with 20 research studies, including "INTRACEPT" ($1.0M).